| PET versus PET/CT dual-modality imaging in evaluation of lung cancer. | |
| | |
MedLine Citation:
|
PMID: 17706528 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Non-small cell lung cancer (NSCLC) accounts for approximately 80% of bronchogenic malignancies. The choice of therapy options, including surgery, radiation therapy, and chemotherapy-used alone or in combination-is based on the tumor stage. Consequently, the accurate determination of tumor size, potential infiltration of adjacent structures, mediastinal lymph node involvement, and the detection of distant metastases are of central importance. The purpose of this article is to summarize the accuracy of dual-modality FDG-PET/CT imaging in staging of NSCLC as compared with FDG-PET alone, and with FDG-PET as well as CT read side by side. Furthermore, an optimized PET/CT protocol for patients who have lung cancer is outlined. |
| | |
Authors:
|
Lutz S Freudenberg; Sandra J Rosenbaum; Thomas Beyer; Andreas Bockisch; Gerald Antoch |
Related Documents
:
|
19998468 - Pseudometastasis secondary to histoplasmosis infection: false-positive pet/ct findings. 22069078 - Modulatory effects of acupuncture on resting-state networks: a functional mri study com... 17854148 - (18)f-dg pet/ct in detection of recurrence and metastasis of colorectal cancer. 17938748 - Comparison of 11c-choline-pet/ct and whole body-mri for staging of prostate cancer. 20591608 - Radiologic and pathological correlation of staging of rectal cancer with 3 tesla magnet... 10223268 - +gz associated stenosis of the cervical spinal canal in fighter pilots. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Radiologic clinics of North America Volume: 45 ISSN: 0033-8389 ISO Abbreviation: Radiol. Clin. North Am. Publication Date: 2007 Jul |
Date Detail:
|
Created Date: 2007-08-20 Completed Date: 2007-11-09 Revised Date: 2010-04-13 |
Medline Journal Info:
|
Nlm Unique ID: 0123703 Medline TA: Radiol Clin North Am Country: United States |
Other Details:
|
Languages: eng Pagination: 639-44, v Citation Subset: AIM; IM |
Affiliation:
|
Department of Nuclear Medicine, University of Duisburg, Hufelandstrasse 55 D-45122, Essen, Germany. lutz.freudenberg@uni-essen.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Carcinoma, Non-Small-Cell Lung
/
pathology,
radiography*,
radionuclide imaging* Contrast Media Fluorodeoxyglucose F18 / diagnostic use Humans Lung Neoplasms / pathology, radiography*, radionuclide imaging* Neoplasm Metastasis Neoplasm Staging Radiopharmaceuticals / diagnostic use Sensitivity and Specificity Tomography, Emission-Computed* Tomography, X-Ray Computed* |
| Chemical | |
Reg. No./Substance:
|
0/Contrast Media; 0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18 |
| Comments/Corrections | |
Republished in:
|
Thorac Surg Clin. 2010 Feb;20(1):25-30
[PMID:
20378058
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Impact of PET on radiation therapy planning in lung cancer.
Next Document: F-18 fluorodeoxyglucose-positron emission tomography imaging for primary breast cancer and loco-regi...